Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Pharmaceuticals market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

20 Item(s)

Page 1 of 2

  1. Global Cancer Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Sep-2016
    , Product code: HBI-1321015
    The global cancer biomarkers market is anticipated to reach around $17 billion by 2022, with an estimated CAGR of 12.6% from 2016 to 2022. The market growth is driven by factors such as increasing prevalence of cancer, various technological developments in omics technologies; increased demand for personalized medicines especially in cancer therapies, rising number of clinical trials in developed as well as developing countries; favorable government research funding for cancer research; and rising R&D expenditures by pharmaceutical companies. However, poorly suited regulatory and reimbursement systems of biomarker tests and huge capital investments for biomarker discovery and development are restricting the growth of this market.
    $3,900.00

  2. Global Metabolomic Technology Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Aug-2016
    , Product code: HAD-2710816
    The global metabolomics technology market is estimated to register robust growth in 2016- 2022 and is expected to grow at CAGR of 30.5% during 2016-2022. The metabolomics technology market is segmented on the basis of application, technique, indication and geography. The application segment is segmented into discovery & drug assessment, toxicology testing, biomarker discovery, nutrigenomics, and others. The technique segment is segmented into detection techniques and separation techniques. The indication segment is also segmented into cardiology, oncology, neurology and others. In indication segment cardiology accounts to large market share, the dominance is majorly driven by the increasing prevalence of cardiovascular diseases across the globe. Whereas the oncology segment is expected to grow with the high CAGR during the forecasted period 2016-2022.
    $3,900.00

  3. Global Continuous Renal Replacement Therapy (CRRT) Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Jul-2016
    , Product code: HME-2221115
    The global continuous renal replacement therapy (CRRT) market is growing at the CAGR of 7.69% and will contribute $1290 million till 2022. In regional outlook, market is divided into North America, Europe, Asia Pacific and Rest of the World. Asia Pacific is the fastest growing global continuous renal replacement therapy (CRRT) market, in terms of revenue in forecast period. Increasing geriatric population, rising healthcare infrastructure are the major reasons which boost the Asia Pacific region’s growth in the global continuous renal replacement therapy (CRRT) market. India and China are the two major countries in Asia Pacific region. Europe is a dominating region in global continuous renal replacement therapy (CRRT) market. The major reason which enhances the European region is the increasing prevalence of acute kidney injury patients, approval of anti-coagulants and CRRT machine for multiple applications. North American region is also a growing market for global continuous renal replacement therapy (CRRT) market. The reason being the presence of large number of major players in this area, rising prevalence of kidney failure due to rising diabetes, cancer and other chronic diseases. Rest of the world is showing low market growth, but government initiatives regarding kidney diseases therapies is expected to fuel the market growth in this region. Brazil is the major country in terms of revenue generation
    $3,900.00

  4. Global Vaccines & Vaccination Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 – 2022

    By: Occams Research
    , Published: Jun-2016
    , Product code: HBI-430814
    The global vaccines & vaccination market is expected to grow at the CAGR of 10.5% during 2016-2022. The market has generated revenue of more than $ 467 million in 2016 and is projected to reach up to $ $769.4 million by 2022. Due to rising use of adjuvants in vaccine-preventable diseases, increasing government investments and initiatives, rising company investments in vaccine development and increasing initiatives by non-government organizations become the major drivers which help to increase the market of vaccines & vaccination globally. Due to increasing prevalence of diseases such as HIV/AIDS, cancer and allergy, there is an increase in the demand of adjuvants vaccine. According to American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide. It is seen that more than 8% population is suffering from food allergy, globally, among which approximately 6% aged 0-2 years, 9% aged 3-5 years and nearly 8% aged 6-10 years, approximately 8% aged 11-13 years and more than 8.5% aged 14-18 years suffer from food allergy globally. The developing regions such as India, China has been on an uprising trend in terms of severity as well as prevalence of diseases. These allergic diseases contain asthma, rhinitis, anaphylaxis, drug, food and insect allergy and many more. Approx. 20% to 30 % of total population suffers from at least one of these allergic diseases in India among which 20% to 30% of the population suffers from allergic rhinitis and 15% have asthma.
    $3,900.00

  5. Global AntiFungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Jun-2016
    , Product code: HME-280714
    The global antifungal agents market was estimated to grow around $10,200 million and it is expected to experience robust growth during 2016-2022.Antifungal agent is basically a drug which helps in detecting and eliminating fungal pathogens from foreign body with less toxic side effects to the body.These agents are also helpful in wide range of applications such as ointments, drugs and others.
    $3,900.00

  6. Global Allergy Diagnostics and Treatments Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Jun-2016
    , Product code: HME-1491015
    The global allergy diagnostics and treatment market is expected to grow with CAGR of 12.67% in the forecasted period of 2016-2022. The key factors driving the global allergy diagnostics and treatments market are increasing allergies diseases, increasing IVD markets, increasing healthcare expenditure and increasing laboratory automation. Increasing respiratory allergies cases day by day is ultimately increasing the market of allergy diagnostics and treatments. According to American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide. The increasing allergy cases in developing region is the key opportunity to drive the market of allergy diagnostics and treatments. The developing regions such as India, China has been on an uprising trend in terms of severity as well as prevalence. These allergic diseases contains asthma, rhinitis, anaphylaxis, drug, food and insect allergy and many more. Approx. 20% to 30 % of the total population suffers from at least one of these allergic diseases in India in which 20% to 30% of the population suffer from allergic rhinitis and that 15% develop asthma. Thus the increasing cases of allergy is driving the market of allergy diagnostic and treatment in India.
    $3,900.00

  7. Global Breast Biopsy Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Jun-2016
    , Product code: HME-1531015
    The global breast biopsy market is estimated to grow at a CAGR of 12.1% and will contribute $769 million by 2022. Rising breast cancer incidences in women’s are one of the major factors that drive the global breast biopsy market. There are many other reasons such as rising women population, growing awareness regarding breast cancer and so on. Breast biopsy tests are generally used for diagnosing breast cancer and also as a checkup for other ailments in the breast, such as lump etc. and also breast cancer if identified during physical examination. There are many drivers of the global breast biopsy market. Increasing prevalence of female breast cancer is one of the major factors. The region with higher number of women’s are likely to act as a growth region for this market, Asia Pacific is the growing market in breast biopsy. Breast cancer is one of the common cancers in women worldwide. More than 3 million cases worldwide are being diagnosed for cancer. This data is expected to grow in near future. Rising incidence of cancer is one of the major reasons for the growth of global breast biopsy market. Increasing technology enables to lower the pain in the biopsy procedure and hence enhances the global market. Technology is the key factor that produces highly accurate and précised machineries, which extract the cancerous area with minimal invasion and less pain. This acts as an opportunity for the growth of the global breast biopsy market.
    $3,900.00

  8. Global Cardiac Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Jun-2016
    , Product code: HME-1521015
    The global cardiac biomarker market is expected to generate the revenue of $2,225.9 million by 2022, registering a CAGR of 19.5% from 2016 to 2022. The prevention of cardiac diseases, by active monitoring the heart conditions by using cardiac biomarker testing is the newest approach for obtaining fastest output of immediate diagnosing and treatment of cardiac deceases. Cardiac biomarkers are made by protein-based traceable substances used as an indicator to assess biological state and for diagnosing the proactive purposes associated with heart. Cardiac biomarkers are also used as risk calculation for various cardiovascular diseases (CVDs), including myocardial congestive heart failure, infraction, acute coronary syndrome (ACS) among others deceases.
    $3,900.00

  9. Global Central Nervous System (CNS) Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: Jun-2016
    , Product code: HBI-2031115
    A biomarker is a biological feature that are used to measure the biological state, presence of diseases or progress of effects of treatment. It helps in understanding various chronic diseases, its effects on exposure to certain environmental conditions and also in identification of people who are at high risk of developing the same disease being diagnosed. The demand for CNS biomarker has increased with the development of in proteomics, genomics and imaging system, which is a major drivers of the Global Central Nervous System Biomarkers Market. The global CNS biomarker market is witnessing a moderate to high growth in the recent years and is expected to continue so on in the near future. The global CNS biomarker market is expected to reach up to $ 6.2 billion by 2022 growing at 10.4% CAGR during 2016-2022.
    $3,900.00

  10. Global Genetic Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

    By: Occams Research
    , Published: May-2016
    , Product code: HBI-1331015
    Genetic testing is a type of medical tests that identifies changes in chromosomes, proteins or in genes. The results of this type of tests confirms the genetic issues if any in patients. Genetic testing represents the most rapidly expanding segment in the molecular diagnostics market globally. Growing incidence of genetic diseases opens up new opportunities for genetic testing. The conversion of genetic testing from being a service-driven to a product-driven market is expected to provide a thrust to the diagnostic companies for the expansion of their business globally. The market for screening the Diagnostic, newborns, rare and fatal disorders, and predicting the probability of occurrence of diseases is likely to expand. Mainly, genetic tests to screen the newborns are expected to expand immensely over the coming years. Genetic testing is a sophisticated and typical form of medical testing to identify smallest changes in genes, proteins or in chromosomes that are associated with problematic diseases. The positivity or negativity of such tests can confirm suspected genetic condition and helps the doctors, physician with greater precision towards treating in genetic disorder.
    $3,900.00

20 Item(s)

Page 1 of 2